CORALLEEN: A Phase 2 Clinical Trial of Multi-agent Chemotherapy or Letrozole Plus Ribociclib (LEE011) as Neoadjuvant Treatment for Postmenopausal Patients With Luminal B/HER2-negative Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 18 Aug 2017
At a glance
- Drugs Letrozole (Primary) ; Ribociclib (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms CORALLEEN
- 02 Jun 2052 Please do not auto-populate treatment arms from registry source.
- 02 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 25 May 2017 Data from this trial will be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), as reported in a NanoString Technologies media release.